C-reactive protein-guided approach may shorten length of antimicrobial treatment of culture-proven late-onset sepsis: An intervention study

Brazilian Journal of Infectious Diseases

Volumn 11, Issue 2, 2007, Pages 240-245

  Couto, Renato C ^a,b   Barbosa, José A A ^a   Pedrosa, Tânia M G ^a   Biscione, Fernando M ^a  

^a FEDERAL UNIVERSITY OF MINAS GERAIS   (Brazil)

^b NONE   (Brazil)

Author keywords

Antibiotics; C reactive protein; Neonatal intensive care units; Newborn; Sepsis

Indexed keywords

ANTIINFECTIVE AGENT; C REACTIVE PROTEIN;

ANTIMICROBIAL THERAPY; ARTICLE; BLOOD CULTURE; CATHETER INFECTION; CENTRAL VENOUS CATHETER; CONTROLLED STUDY; DRUG EFFICACY; DRUG WITHDRAWAL; GRAM NEGATIVE SEPSIS; HUMAN; INFANT; MAJOR CLINICAL STUDY; MORTALITY; MYCOSIS; NEWBORN; NEWBORN SEPSIS; NONHUMAN; PROSPECTIVE STUDY; PROTEIN ANALYSIS; PROTEIN BLOOD LEVEL; RELAPSE; RELIABILITY; TREATMENT DURATION;

EID: 34547096478     PISSN: 14138670     EISSN: None     Source Type: Journal    
DOI: 10.1590/S1413-86702007000200015     Document Type: Article

References (37)

1. Stoll B.J., Gordon T., Korones S., et al. Late-onset sepsis in very low birth weight neonates: a report from the National Institute of Child Health and Human Development Neonatal Reseach Network. J Pediatr 1996;129:63-71.
2. Stoll B.J., Hansen N., Fanaroff A.A., et al. Late-onset sepsis in very low birth weight neonates: the experience of the NICHD Neonatal Reseach Network. Pediatrics 2002;110:285-91.
3. Makhoul I.R., Sujov P., Smolkin T., et al. Epidemiological, clinical, and microbiological characteristics of late-onset sepsis among very low birth weight infants in Israel: a national survey. Pediatrics 2002;109:34-9.
4. Isaacs D., Barfield C., Clothier T., et al. Late-onset infections of infants in neonatal units. J Paediatr Child Health 1996;32:158-61.
5. Rubin L.G., Sánchez P.J., Siegel J., et al. Evaluation and treatment of neonates with suspected late-onset sepsis: a survey of neonatologists' practices. Pediatrics 2002;110:E42.
6. Yancey M.K., Duff P., Kubilis P., et al. Risk factors for neonatal sepsis. Obstet Gynecol 1996;87:188-94.
7. Isaacs D. Rationing antibiotic use in neonatal units. Arch Dis Child Fetal Neonatal Ed 2000;82:F1-F2.
8. Ehl S., Gering B., Bartmann P., et al. C-reactive protein in a useful marker for guiding duration of antibiotic therapy in suspected neonatal bacterial infection. Pediatrics 1997;99:216-21.
9. Adams-Chapman I., Stoll B.J. Adjunctive therapies for treatment or prevention of sepsis. Semin Pediatr Infect Dis 2001;12:211-9.
10. Ng P.C. Diagnostic markers of infection in neonates. Arch Dis Child Fetal Neonatal Ed 2004;89:229-35.
11. Garner J.S., the Hospital Infection Control Practices Advisory Committee. Guideline for isolation precautions in hospitals. Infect Control Hospital Epidemiol 1996;17:53-80.
12. Guidelines for prevention of nosocomial pneumonia. Centers for Disease Control and Prevention. MMWR Recomm Rep 1997;46(RR-1):1-79.
13. Pearson M.L. Guideline for prevention of intravascular device-related infections. Hospital Infection Control Practices Advisory Committee. Infect Control Hosp Epidemiol 1996;17:438-73.
14. Garner J.S., Jarvis W.R., Emori T.G., et al. CDC definitions for nosocomial infections, 1988. Am J Infect Control 1988;16:128-40.
15. Goldmann D.A., Weinstein R.A., Wenzel R.P., et al. Strategies to prevent and control the emergence and spread of antimicrobial-resistant microorganisms in hospitals. A challenge to hospital leadership. JAMA 1996;275:234-40.
16. Hengst J.M. The role of C-reactive protein in the evaluation and management of infants with suspected sepsis. Adv Neonatal Care 2003;3:3-13.
17. Steel D.M., Whitehead A.S. The major acute phase reactants: C-reactive protein, serum amyloid P component and serum amyloid A protein. Immunol Today 1994;15;81-8.
18. Pepys M.B., Baltz M.L. Acute phase proteins with special reference to C-reactive protein and-related proteins (pentaxins) and serum amyloid A protein. Adv Immunol 1983;34:141-212.
19. Ishibashi M., Takemura Y., Ishida H., et al. C-reactive protein kinetics in newborns: application of a high-sensitivity analytic method in its determination. Clin Chem 2002;48:1103-6.
20. Pepys M.B. C-reactive protein fifty years on. Lancet 1981;1:653-7.
21. Pourcyrous M., Bada H.S., Korones S.B., et al. Significance of serial C-reactive protein responses in neonatal infection and other disorders. Pediatrics 1993;92:431-5.
22. Gabay C., Kushner I. Acute-phase proteins and other systemic responses to inflammation. N Engl J Med 1993;340:448-54.
23. Benitz W.E., Han M.Y., Madan A., Ramachandra P. Serial serum C-reactive protein levels in the diagnosis of neonatal infection. Pediatrics 1998;102:E41.
24. Ehl S., Gering B., Pohlandt F. A detailed analysis of changes in serum C-reactive protein levels in neonates treated for bacterial infection. Eur J Pediatr 1999;158:238-42.
25. Young B., Gleeson M., Cripps A.W. C-reactive protein: a critical review. Pathology 1991;23:118-24.
26. Franz A.R, Steinbach G., Kron M., Pohlandt F. Reduction of unnecessary antibiotic therapy in newborn infants using interleukin-8 and C-reactive protein as markers of bacterial infections. Pediatrics 1999; 104:447-53.
27. Kawamura M., Nishida H. The usefulness of serial C-reactive protein measurement in managing neonatal infection. Acta Paediatr 1995; 84:10-3.
28. Philip A.G., Mills P.C. Use of C-reactive protein in minimizing antibiotic exposure: experience with infants initially admitted to a well-baby nursery. Pediatrics 2000;106:401-11.
29. Russell G.A., Smyth A., Cooke R.W. Receiver operating characteristic curves for comparison of serial neutrophil band forms and C-reactive protein in neonates at risk for infection. Arch Dis Child 1992; 67:808-12.
30. Chiesa C., Panero A., Osborn J.F., et al. Diagnosis of neonatal sepsis: a clinical and laboratory challenge. Clin Chem 2004;50:279-87.
31. Franz A.R., Bauer K., Schalk A., et al. Measurement of interleukin 8 in combination with C-reactive protein reduced unnecessary antibiotic therapy in newborn infants: a multicecenter, randomized, controlled trial. Pediatrics 2004;114:1-8.
32. Jaye D.L., Waites K.B. Clinical applications of C-reactive protein in pediatrics. Pediatr Infect Dis J 1997;16:735-46.
33. Stoll B.J., Hansen N., Fanaroff A.A., et al. Changes in pathogens causing early-onset sepsis in very-low-birth-weight infants. N Engl J Med 2002;347:240-7
34. American College of Obstetricians and Gynecologists, Committee on Obstetric Practice. Prevention of early-onset group B streptococcal disease in newborns [Opinion 173]. Washington, D.C.: American College of Obstetricians and Gynecologists, 1996.
35. CDC. Prevention of perinatal group B streptococcal disease: a public health perspective. MMWR 1996;45(RR-7):1-24.
36. Zaidi A.K., Huskins W.C., Thaver D., et al. Hospital-acquired neonatal infections in developing countries. Lancet 2005;365:1175-88.
37. Gray J.E., Richardson D.K., McCormick M.C., Goldmann D.A. Coagulase-negative staphylococcal bacteremia among very low birth weight infants: relation to admission illness severity, resource use, and outcome. Pediatrics 1995;95:225-30.